In the last trading session, 83164.0 shares of the NeuroSense Therapeutics Ltd (NASDAQ:NRSN) were traded, and its beta was 1.28. Most recently the company’s share price was $1.09, and it changed around -$0.03 or -2.68% from the last close, which brings the market valuation of the company to $25.21M. NRSN currently trades at a discount to its 52-week high of $2.33, offering almost -113.76% off that amount. The share price’s 52-week low was $0.51, which indicates that the current value has risen by an impressive 53.21% since then. We note from NeuroSense Therapeutics Ltd’s average daily trading volume that its 10-day average is 0.11 million shares, with the 3-month average coming to 287.56K.
NeuroSense Therapeutics Ltd stock received a consensus recommendation rating of Buy, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended NRSN as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
NeuroSense Therapeutics Ltd (NASDAQ:NRSN) trade information
Instantly NRSN has showed a red trend with a performance of -2.68% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.1326 on recent trading dayincreased the stock’s daily price by 3.76%. The company’s shares are currently down -9.17% year-to-date, but still up 4.81% over the last five days. On the other hand, NeuroSense Therapeutics Ltd (NASDAQ:NRSN) is 23.35% up in the 30-day period. We can see from the shorts that 0.32 million shares have been sold at a short interest cover period of 2.01 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -7.06%.
NRSN Dividends
NeuroSense Therapeutics Ltd’s next quarterly earnings report is expected to be released in February.
MEITAV INVESTMENT HOUSE LTD, with 0.2597% or 40000.0 shares worth $44800.0 as of 2024-06-30, holds the second largest percentage of outstanding shares.
